Focal Spot, Fall/Winter 2000 by unknown
Washington University School of Medicine
Digital Commons@Becker
Focal Spot Archives Focal Spot
Fall 2000
Focal Spot, Fall/Winter 2000
Follow this and additional works at: http://digitalcommons.wustl.edu/focal_spot_archives
This Book is brought to you for free and open access by the Focal Spot at Digital Commons@Becker. It has been accepted for inclusion in Focal Spot
Archives by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation








|y orizons in Screening and Treating 1    j-| M jrj Cancer 
I WashingtonUniversity in StLouis 
SCHOOL OF MEDICINE 
R. Gilbert Jost, MD 
Interim Chair, Department of Radiology 
Interim Director of the Institute 
Dear Colleagues and Friends of Mallinckrodt Institute: 
Chancellor Mark Wrighton recently presented to the academic commu- 
nity a new logotype for Washington University in St. Louis—a logo that 
"draws upon our history, traditions, and location." The logotype was 
heartily approved by the University Council and the Board of Trustees. 
All departments and schools were encouraged to use the logotype as a 
clear and consistent means of showing association with the University. 
As we prepare to meet the challenges facing academic medicine, it is 
extremely important that our national and international audiences 
easily and consistently recognize the name of Mallinckrodt Institute 
of Radiology as well as its affiliation with one of the nation's 
top-ranked universities and medical schools. Therefore, I am pleased 
to present the Institute's official, new logo, which has been approved 
by the University and by the School of Medicine. A larger version of 
the logo appears on the inside back cover of this publication. 
Sincerely, 
B om&0$- 
R. Gilbert Jost, MD 
\ 111 > Mallinckrodt Institute 
iVllItofR f Radiology 
510 South Kingshighway Boulevard, St. Louis, Missouri 63110, (314) 362-7100, Fax: (314) 361-5428 
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SPOT NEWS 
PROFILE: JOHN EICHLING, PHD 
As Washington University's first radiation safety 
officer, John Eichling was a vigilant sentinel for 
one of the most extensive and diverse radiation 
safety programs worldwide. At his retirement, 
after 37 years at the medical center, he shares 
memories of MIR's early days. 
DIAGNOSING PULMONARY EMBOLISM 
20 FYI 
As part of a multi-institutional study, researchers 
at Washington University Medical Center are evalu- 
ating spiral computed tomography as a diagnostic 
tool for acute pulmonary embolism, a condition that 
annually affects an estimated 600,000 patients in the 
United States. 
NEW HORIZONS IN SCREENING AND TREATING LUNG CANCER 
A collaborative effort among diagnostic radiologists, 
nuclear physicians, and radiation oncologists to 
assess diagnostic technology and cancer treatments 
may lead to reduced mortality rates for lung cancer, 
the leading cause of cancer deaths worldwide. 
A TREATMENT ALTERNATIVE FOR PATIENTS 
WITH AORTIC DISSECTION 
Interventional radiologists, vascular and cardio- 
thoracic surgeons, and cardiologists combine 
radiological and endovascular techniques to pro- 
vide revolutionary, minimally invasive treatments 
for patients with thoracic aortic dissection. 
ON THE COVER  According to the American Cancer Society, an estimated 164,000 new 
cases of lung cancer were diagnosed in the year 2000. If lung cancer is found and treated 
early before it has spread to lymph nodes and other organs, the five-year survival rate 
is about 42 percent. Doctors Farrokh Dehdashti, Richard Slone, and Jeffrey Bradley 
(right) are working to boost patient survival.  Photograph by Tim Parker. 




James Purdy, PhD, 
professor of radiology and 
chief of the radiation on- 
cology physics section, 
received the American 
Society for Therapeutic 
Radiology and Oncology's 
(ASTRO) highest honor, the 
Gold Medal Award, at the 
society's annual meeting in 
Boston in late October. 
Established in 1958, 
ASTRO is the largest society 
of radiation oncologists 
worldwide. The first Gold 
Medal Award was presented 
in 1977 to highlight ASTRO 
members' outstanding 
contributions to radiation 
oncology. 
Purdy's research efforts 
in computer-aided treatment 
planning, particularly 3-D 
conformal radiation therapy 
(3-D CRT) and intensity- 
modulated radiation therapy 
(IMRT), continue to have a 
profound effect on the prac- 
tice of radiation therapy. An 
early advocate of 3-D CRT 
quality assurance (QA), 
Purdy now serves as direc- 
tor of the national 3-D QA 
Center that oversees 3-D 
CRT clinical trials. The 
3-D QA Center is based at 
Mallinckrodt Institute of 
Radiology (MIR) and is 
funded by the National 
Cancer Institute. 
Prior to joining the 
MIR faculty in 1973, Purdy 
trained with doctors Robert 
Shalek and Gilbert Fletcher, 
both former ASTRO Gold 
Medal recipients, at the Uni- 
versity of Texas M.D. Ander- 
son Cancer Center. In his 
acceptance speech, Purdy 
said that at M. D. Anderson, 
he "learned the importance 
of the close interaction of 
physicists and physicians 
needed in a radiation oncol- 
ogy clinic." That interaction, 
he added, continued with 
his physician colleagues in 
St. Louis, particularly 
doctors Carlos Perez and 
William Powers. Perez, 
professor of radiology and 
director of the Institute's 
Radiation Oncology Center 
for the past 25 years, and 
Powers, who preceded 
Perez as director, received 
the ASTRO Gold Medal in 
1992 and 1988, respectively. 
Purdy was named chief 
of radiation physics at MIR 
in 1976 and was appointed 
professor of radiology in 
1983. He directs the physics 
residency program, the first 
such program to be approved 
by the Commission of 
Accreditation of Medical 
Physics Education Pro- 
grams. Purdy has authored 
and coauthored more than 
230 scientific articles and 
book chapters and has 
edited seven textbooks. He 
also serves as senior physics 
editor for The International 
Journal of Radiation Oncol- 
ogy, Biology, and Physics. 
Purdy is a former presi- 
dent and chairman of the 
board of the American Asso- 
ciation of Physicists in Medi- 
cine (AAPM) and a past 
chairman of the Board of 
Chancellors of the American 
College of Medical Physics 
(ACMP). In 1996 he received 
the ACMP's Marvin M.D. 
William Professional 
Achievement Award and, in 
1997, the AAPM's William D. 
Coolidge Award—the two 
highest honors bestowed 
by United States medical 
physics societies. He is a fel- 
low of the American College 





Franz Wippold, MD, 
associate professor of radiol- 
ogy, was named chief of 
MIR's neuroradiology sec- 
tion. He succeeds Daniel 
Kido, MD, who left the Insti- 
tute in late August to join the 
faculty of Loma Linda Uni- 
versity Medical Center 
in California. 
Wippold came to 
Mallinckrodt Institute as a 
fellow in neuroradiology, 
having previous residency 
training in neurology and in 
radiology (chief resident, 
diagnostic radiology) at 
Walter Reed Army Medical 
Center. Prior to joining the 
MIR faculty in 1986, Wippold 
was chief of neuroradiology 
at Walter Reed and assistant 
professor of radiology at the 
Uniformed Services Univer- 
sity of the Health Sciences 
(USUHS) in Bethesda, 
Maryland. Wippold currently 
holds the academic title of 
adjunct professor of radiol- 
ogy/nuclear medicine at the 
F. Edward Hebert School of 
Medicine, USUHS. 
Wippold is a fellow of 
the American College of 
Radiology and of the Ameri- 
can College of Angiology. 
He received the MIR Fellow 
Teaching Award in 1983 and 
the Teacher of the Year 
Award in 1991. He serves as 
a reviewer for the medical 
journals Radiology and the 
American Journal of 
Roentgenology. 
MALLINCKRODT INSTITUTE OFRADIOLOI 
Researchers 
share prize 
Three pioneers in the 
field of cognitive neuro- 
science received the 2001 
Grawemeyer Award for 
Psychology presented by 
the University of Louisville, 
Kentucky: Marcus Raichle, 
MD; Steven Petersen, PhD; 
and Michael Posner, PhD. 
Raichle, professor of 
radiology and of neurology 
and neurobiology, and 
codirector of MIR's Division 
of Radiological Sciences; 
Petersen, professor of neu- 
rology and neurobiology and 
of radiology, and chief of 
WUSM's neuropsychology 
division; and Posner, a 
Washington University alum- 
nus and founding director of 
the Sackler Institute at Weill 
Medical College of Cornell 
University, collaborated in 
the mid-1980s to advance 
the methods for isolating 
and measuring the brain's 
mental functions. Their 
success in imaging the 
brain's functions led to 
discoveries of neuroanatom- 
ical networks that support 
language and attention 
processes. 
The Grawemeyer 
Foundation at the University 
of Louisville annually 
has awarded $1 million for 
accomplishments in music 
composition, education, 
ideas improving world 
order, and religion. This 
year marks the first presen- 
tation of the Grawemeyer 
Award for Psychology. 
RSNA awards 
seed grants 
Programs sponsored by 
the Radiological Society of 
North America (RSNA) 
Research and Education 
Foundation annually assist 
young investigators in the 
early stages of their careers 
in radiology research, educa- 
tion, and related scientific 
disciplines. RSNA has 
announced the presentation 
of seed grants to the follow- 
ing Mallinckrodt Institute 
physicians and scientists: 
■ Steven Don, MD, assistant 
professor of radiology, 
received an award of 
$25,000 for his research 
on "Exposure reduction 
in neonatal chest radiog- 
raphy using computed 
radiography." 
■ James Duncan, MD, PhD, 
assistant professor of 
radiology, received a 
$25,000 seed grant for his 
investigation of "Optical 
imaging of peripheral 
vascular disease." 
■ Jie Zheng, PhD, instructor 
in radiology, received an 
award of $25,000 for his 
research on "Diagnosis of 
pulmonary emboli with 
MR perfusion and angiog- 






At the American Col- 
lege of Radiology's (ACR) 
annual meeting in Septem- 
ber, Robert Myerson, PhD, 
MD, a radiation oncologist, 
and Jeffrey Williamson, 
PhD, a radiation physicist, 
were among the 96 outstand- 
ing clinicians and scientists 
named as ACR fellows. 
Fellowships are 
awarded to ACR members 
for significant accomplish- 
ments as a teacher of radiol- 
ogy, for scientific or clinical 
research, or for service to 
organized medicine. More 
than 32,000 radiologists, 
radiation oncologists, and 
medical physicists support 
the ACR's programs focus- 
ing on the practice of radiol- 
ogy and the delivery of 
comprehensive radiological 
health services. 
Myerson joined the 
MIR faculty in 1984 and was 
appointed professor of radi- 
ology in 1997. He serves as 
chairman of MIR's Radiation 
Oncology Center Research 
Committee and as chief of 
the hyperthermia and GI 
service. He was elected in 
1999 as the North American 
Hyperthermia Society's 
councilor for medicine and 
has been included in several 
editions of The Best Doctors 
in America. Myerson is a 
member of the ACR's Com- 
mittee on Residency Train- 
ing in Radiation Oncology of 
the Commission on Educa- 
tion. He was the associate 
director of residency training 
for MIR's Radiation Oncol- 
ogy Center from 1990 to 
1998. He currently serves as 
a manuscript referee for the 
scientific publications Can- 
cer; International Journal 
of Radiation Oncology, 
Biology, and Physics; Inter- 
national Journal of Hyper- 
thermia; and Journal of 
Clinical Oncology. 
Williamson is professor 
of radiology and associate 
chief of the Radiation On- 
cology Center's physics 
section. Prior to joining the 
MIR faculty in 1989, he held 
academic appointments at 
the University of Arizona and 
the University of Minnesota. 
Williamson is a fellow of the 
American Association of 
Physicists in Medicine 
(AAPM). He is associate 
editor of the journal Medical 
Physics and past associate 
editor of The International 
Journal of Radiation Oncol- 
ogy, Biology, and Physics. 
He is a past member of 
the AAPM's Board of Direc- 
tors and currently serves 
as chair of the AAPM Radia- 
tion Therapy Committee. 
Williamson is a member of 
the U.S. Nuclear Regulatory 
Commission's Advisory Com- 
mittee on Medical Use of Iso- 
topes and serves on the Joint 
ACR/American Society for 
Therapeutic Radiology and 
Oncology (ASTRO) Govern- 
ment Relations Committee. 
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John Eichling, PhD 
professor of radiology and 
Washington University's 
radiation safety officer 
by Kirstin Blase and Vicki Kunkler 
As with many of life's 
experiences that often 
lead to memorable events, 
the beginnings are usually 
happenstance. Such was 
John Eichling's career at Mallinck- 
rodt Institute of Radiology (MIR). 
In 1963 Eichling and his wife 
Carol lived in Oklahoma, where he 
was head of the Department of 
Physics at Northeastern Oklahoma 
State University. A native Okla- 
homan, Eichling earned a Bachelor 
of Science degree at Northeastern 
Oklahoma State and a master's 
degree at Oklahoma University, 
Norman. 
Carol, a pre-med student, 
had received a scholarship to 
attend Washington University 
The PET team (circa 1974). 
Michel Ter-Pogossian 
is at left front; John Eichling 
is sixth from right. 
School of Medicine (WUSM). 
Although Eichling was not quite 
sure what he would do in Missouri, 
he knew this was a good opportu- 
nity for Carol. After Eichling 
arrived in St. Louis, WUSM's 
Dean Dempsey suggested Eichling 
contact Michel Ter-Pogossian, a 
research scientist who was plan- 
ning the installation of a cyclotron 
in the basement of Barnard Free 
Skin and Cancer Hospital at Wash- 
ington University Medical Center. 
7 
As it turned out, this would be 
tthe nation's first cyclotron installed 
in a medical center and dedicated 
to biomedical research. Armed 
with a master's degree in nuclear 
physics, Eichling was the first pro- 
fessional hired to work with the 
WUSM cyclotron. 
After 37 years at the medical 
center, Eichling decided to retire 
on December 31, 2000. He and 
Carol plan to spend much of their 
time on a 130-acre farm in Warren 
County, Missouri. Portions of the 
old farmhouse on the property were 
built in 1820, and the Eichlings' pas- 
sion for antiques and restoration 
have turned the homestead into 
"something of a museum and 
private park." But before he turned 
in his badges and closed his office 
door for the last time, Eichling 
shared some history and a bit of nos- 
talgia about his early days at MIR. 
The application of radionuclide 
tracers to the biomedical sciences 
began at Washington University 
in the early 1930s, with the con- 
struction of a cyclotron on the Uni- 
versity's main campus following 
shortly thereafter. The construction 
of the cyclotron and partial funding 
by Mallinckrodt Institute was in 
step with Doctor Sherwood Moore's 
(MIR's first director) visionary plan 
to keep the Institute at the forefront 
of radiology technology develop- 
ments. The early studies of 
radionuclide brain tumor detection 
conducted by Ter-Pogossian and 
Dr. Henry Schwartz were mile- 
stones in nuclear medicine science. 
The decision to install a cyclotron 
at the new medical center and to 
consolidate radioactive tracer pro- 
duction into a centralized radioiso- 
tope laboratory at Mallinckrodt 
Institute came at a time when the 
field of nuclear medicine was rela- 
tively new. 
In 1963 MIR's nuclear 
medicine group [The 
This era, of course, was before 
the advent of portable units, image 
intensifiers, magnetic resonance 
imaging (MRI), computed tomogra- 
phy (CT), positron emission tomog- 
raphy (PET), ultrasound imaging, 
and dedicated mammography. In 
fact, the Nuclear Regulatory Com- 
mission (NRC), the U.S. Department 
of Energy, and the National Insti- 
tutes of Health did not exist. The 
University's first cyclotron was 
funded by the Atomic Energy Com- 
mission, from which the NRC and 
the Energy Research and Develop- 
ment Agency were formed. 
...of Memories 
group officially became the Divi- 
sion of Nuclear Medicine in 
1966.] was located on the fifth 
floor of Barnard Hospital and was 
comprised of only three pieces of 
diagnostic equipment: a rectilinear 
scanner, a thyroid uptake unit, and 
a well counter for in vitro tests. 
And the only types of equipment in 
MIR's diagnostic radiology area 
were fixed radiographic units for 
taking individual films and several 
fluoroscopic units. 
Left: At his last Radiation Safety Committee meeting 
in December, Eichling is shown with (left to right) 
doctors Barry Seigel, Gilbert Jost, and Carlos Perez. 
Above: A special memorabilia case was constructed 
and presented to Eichling at the December Radiation 
Safety Committee. 
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Most of the early radionuclide 
research dealt with improving 
images or intensifying images so 
the radiation dose to the patient 
could be reduced. Eichling was one 
of a four- or five-member team 
responsible for research and 
cyclotron operation. It was a result 
of Ter-Pogossian's encouragement 
that Eichling pursued his doctorate 
in biophysics. While working full- 
time at MIR, Eichling attended 
classes at Washington University 
on a part-time basis. By 1970 he had 
completed his doctoral research 
on 0-15 compounds and their use 
to successfully measure blood flow, 
oxygen metabolism, and blood 
volume in the brain. 
Throughout his career, Eichling 
says he has worked with some tal- 
ented researchers on a diverse range 
of projects, including Ter-Pogossian, 
who led the research team that 
developed PET; Mokhtar Gado, MD, 
a neuroradiologist, as they demon- 
strated computed tomography's 
ability to work on a quantitative 
level; Marcus Raichle, MD, an inter- 
nationally known neurologist/neuro- 
biologist as they discovered that 
water, when used as a radiotracer, 
does not behave as a freely diffusible 
marker in biological tissues; and the 
team of radiologists Judy Destouet, 
Barbara Monsees, and Louis Gilula, 
and surgeon Leroy Young who devel- 
oped and patented a radiolucent 
breast implant medium. 
In 1970 Eichling was asked by 
Juan Taveras, MD, then director of 
Mallinckrodt Institute, to serve as 
radiation safety officer, a position 
that would serve not only the Insti- 
tute but the medical campus and 
the main campus as well. Eventu- 
ally more than 900 laboratories 
working with radioactive materials 
and medical programs, such as 
nuclear medicine and radiation 
oncology, would come under 
Eichling's radiation safety watch. 
According to Eichling, Washington 
University has one of the most 
extensive and diverse radiation 
safety programs worldwide. 
In 1970 the radiation safety 
program consisted only of wearing 
external monitors and testing field 
sources. Since then, with the guid- 
ance of the NRC, a thorough pro- 
gram has been developed that now 
includes extensive training in the 
receiving, shipping, and handling 
of radioactive materials; restricted 
ordering; and laboratory inspec- 
tions. The Radiation Safety group 
performs many periodic internal 
audits and on-site inspections to 
evaluate the effectiveness of the 
radiation safety program. 
Eichling adds that he could not 
have handled the tremendous radia- 
tion safety responsibilities without a 
remarkable staff, including Jeanette 
Hardin, Fritzi Imming, Larry John- 
son, and Bonnie Kelly. 
There is a multitude of informa- 
tion and regulation guidelines 
covering every category of radia- 
tion safety, says Eichling. Currently 
in the radiation safety group's 
responsibilities are five gamma 
irradiators; approximately 900 
research laboratories; a large 
nuclear medicine service; five 
clinical chemistry groups; Barnes- 
Jewish Hospital north and south 
campuses, Children's Hospital, and 
Barnes-Jewish Hospital Heart Care 
Institute; radiation oncology's 
numerous accelerators for therapy; 
and 160 diagnostic X-ray units. 
During his Washington Univer- 
sity career, Eichling says he has 
been involved in "just about every- 
thing that is radiation-related at 
Mallinckrodt Institute—research, 
clinical, and education." He has 
been a member of the Institutional 
Radiation Safety Committee since 
1970 and a member of the Radioac- 
tive Drug Research Committee 
since its inception in 1975. He 
was a charter member of the 
Barnes Hospital Electrical Safety 
Committee. 
MALLINCKRODT INSTITUTE OFRADIOLOG) 
Eichling hopes that former 
coworkers will remember him 
as someone who never rejected 
a request for help and always 
investigated a problem thoroughly. 
An interesting footnote to 
Eichling's career: Until his 
retirement Eichling had never been 
away for longer than a few days 
because he wanted to be close by 
in case the University needed him. 
The most memorable aspect 
of his career Eichling says was 
"the opportunity to interact with 
and deal with bright talented peo- 
ple. Working with the best in the 
field has been a rare and enjoyable 
experience." He says he specifi- 
cally appreciated his long-time 
work with doctors Carlos Perez 
and Barry Seigel. And as his 
colleagues would probably attest, 
that feeling is mutual. EM 
The Washington University Medical Center 
Cyclotron (circa 1964). 
John Eichling is not only known for his dedication to the University and MIR, his 
vast wealth of knowledge, and his kind caring manner. He also has a dry sense of humor. 
In the early days of MIR, Eichling says that he and coworkers enjoyed "pulling 
pranks" on each other. One of his favorite reminiscences follows: 
When the cyclotron was first installed in 1964, the researchers wanted to measure the 
energy of the deuteron beam. One way was to measure the distance the ionization path 
traveled in air through a foil. When the lights were turned off in the cyclotron vault, the 
ionization path would be visible—although the radiation level would be very high. Eichling 
and Gene Hood, the cyclotron operator at the time, conspired to double-expose some films so 
the visible ionization path would appear in the photographs as though it was apparently strik- 
ing their hands or abdomens. When they presented the photos to William Powers, MD, then 
director of MIR's Radiation Oncology Center, Powers was horrified. He told them in no 
uncertain terms that they were fools and would probably expire in a few hours. Eichling says 
he and Hood had to do a lot of explaining, but the incident did not inhibit future pranks. 
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DIAGNOSING 
mania/ Embolism 
A study at 
Mallinckiodt Institute 
may benefit patients 
who develop 
embolism. 
by Vicki Kunkler 
According to the Ameri- 
can Heart Association, 
pulmonary embolism 
(PE) has become a 
national health problem in the 
United States and other developed 
countries. An estimated 600,000 
patients in the U.S. annually 
develop PE, with women affected 
more often than men. The disease 
causes more than 60,000 deaths 
each year. 
Pamela Woodard, MD, assis- 
tant professor of radiology, is 
Washington University Medical 
Center's chief investigator for a 
multi-institutional study to deter- 
mine if contrast-enhanced spiral 
computed tomography (CT) can 
be used to definitively diagnose 
acute PE. The study, called 
Prospective Investigation in 
Pulmonary Embolism Diagnosis-II 
(PIOPED-II), is the second phase 
of the original PIOPED study 
that developed criteria for diag- 
nosing PE by ventilation/perfusion 
scintigraphy. 
Pamela Woodard, MD 
■...■ .-.,.;. iiWiifflvBiiitl ,'Miv"--:-  ■ 
Seven additional clinical 
centers are participating in the 
National Institutes of Health- 
funded study: Cornell Medical 
Center (New York City); Duke Uni- 
versity (Durham, North Carolina); 
Emory University (Atlanta); Henry 
Ford Hospital (Detroit); University 
of Calgary (Canada); University 
of Michigan (Ann Arbor); and 
Massachusetts General Hospital 
(Boston). George Washington Uni- 
versity (Maryland) will serve as the 
study's data coordinating center. 
PULMONARY EMBOLISM 
PE is usually a result of deep 
vein thrombosis (DVT). While DVT 
and PE can occur in normal indi- 
viduals, they are common compli- 
cations in patients who have 
undergone orthopedic surgery, 
have cancer, or have other chronic 
illnesses. Clots, called deep venous 
thrombi, form in the deep veins 
of the leg in areas where blood 
flow is slower, or in veins that 
have been exposed to direct 
trauma. When emboli from the 
deep venous thrombi break off, 
they travel to the lungs, lodging in 
the pulmonary arteries as pul- 
monary emboli. These emboli 
obstruct pulmonary arterial blood 
flow, causing shortness of breath, 
sharp pleuritic chest pain, hypoxia, 
and even death. 
DVT and PE often occur 
without warning. Because many 
of the symptoms also occur with 
other diseases, PE is difficult 
to diagnose clinically, thus con- 
tributing to increased mortality, 
prolonged hospitalization, and 
increased healthcare costs. 
DETECTING AND TREATING PE 
Ventiliation/perfusion scintig- 
raphy, a nuclear medicine proce- 
dure that uses radioisotopes to 
produce two-dimensional images 
of lung ventilation and perfusion, 
has been the most common 
method used to diagnose acute 
PE. Ventilation/perfusion scinti- 
graphic studies are read as 
"normal," "low-probability for 
PE," "high-probability for PE," 
and "indeterminate," based on 
previously determined criteria. 
Although normal and high-proba- 
bility results provide clinicians 
with useful information, a large 
number of patients have results 
that are indeterminate. While 
ventilation/perfusion scintigraphy 
is highly sensitive in detecting pul- 
monary emboli, other etiologies 
such as tumor or fibrosis can cause 
similar ventilation/perfusion 
results, producing false-positive 
findings that result in unnecessary 
treatment for patients. 
In order to directly visualize 
PE, pulmonary angiography can be 
performed in patients who have an 
indeterminate ventilation/perfu- 
sion lung scan. However, because 
pulmonary angiography is an 
invasive procedure, it is not often 
performed. 
An early diagnosis and an 
aggressive treatment regimen can 
save lives. Patients who are diag- 
nosed with DVT or acute PE are 
initially treated with intravenous 
heparin, followed by three to six 
months of an oral anticoagulant. 
Patients with smaller emboli are 
usually treated on an outpatient 
basis, whereas those with larger 
emboli are hospitalized. 
SPIRAL CT 
In the early 1970s, researchers 
at Mallinckrodt Institute played a 
key role in the development of the 
medical application of CT, a tech- 
nology that revolutionized the field 
of radiology. For the first time in 
medical history an imaging device 
could produce cross-sectional 
images of the body. The technol- 
ogy's direct visualization of inter- 
nal anatomy allowed physicians to 
differentiate between diseased and 
healthy tissue, to detect blood 
clots and enlarged organs, and to 
detect early-stage tumors. Numer- 
ous studies conducted in the 
following 20 years proved that the 
specific and unique information 
gained from the noninvasive CT 
procedure could eliminate 
exploratory surgery, shorten 
hospital stays, and reduce actual 
surgery time. In most cases CT has 
replaced some of the more expen- 
sive radiological procedures, such 
as angiography, lymphangiography, 
and myelography. 
In 1990 Mallinckrodt Institute 
received one of the first spiral CT 
units developed by Siemens Med- 
ical Systems, Inc. An improved 
version of computed tomography, 
spiral CT offers reduced scanning 
time and lower risks to patients 
with the use of nonionic contrast 
material. Total scanning time 
ranges from a few seconds up 
to one-half minute. Volume CT 
acquisition is achieved with the 
patient taking a single breath-hold, 
thus eliminating respiratory mis- 
registration and image artifacts. 
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monary Embolism 
Washington University PIOPED-II 
Study Coinvestigators 
Roger Yusen, MD, Department of Medicine, 
Division of Pulmonary and Critical Care Medicine 
Jay Heiken, MD, Mallinckrodt Institute of 
Radiology, Division of Diagnostic Radiology 
(computed body tomography) 
Henry Royal, MD, Mallinckrodt Institute of 
Radiology, Division of Nuclear Medicine 
Daniel Brown, MD, Mallinckrodt Institute 
of Radiology, Division of Diagnostic Radiology 
(vascular and inter ventional radiology) 
Brian Rubin, MD, Department of Surgery, 
Division of General Surgery (vascular) 
Audrea Lamb, RN, study coordinator 
Sheila Agen, RT, research assistant 
HIM 11 
In the PIOPED-II study 
Woodard will use the latest 
Siemens Medical Systems multide- 
tector spiral CT system. This new 
system with its four detectors can 
scan four times faster and provide 
four times better resolution than 
the older single detector spiral 
CT scanner. 
STUDY CRITERIA 
Over the next 18 months the 
national study hopes to enroll 133 
patients at each study center, 
based on the area's gender and 
ethnic population. In St. Louis, 
Woodard will begin recruiting 
patients in September. 
Volunteers for the study must 
be 18 years of age or older and 
suspected of hav- 
ing acute PE. 
They may be 
treated on either 
an in- or outpa- 
tient basis. 
Patients who 
are allergic to 
contrast media, 
have renal insuffi- 
ciency, or who 
are pregnant 
may not partici- 
pate in the study. 




spiral CT. A non- 
ionic contrast 
agent will be used 
during the spiral 




angiography and ultrasonography 
of the lower extremities. Follow-up 
assessments wiU be conducted at 
one, three, and six months follow- 
ing enrollment. EM 
Editor's note: Physicians who are 
interested in enrolling patients in 
the PIOPED-II study can contact 
the patient coordinator, Audrea 
Lamb, RN, at 314-855-5393 
(pager) or 314-747-4633 (office). 
Contrast-enhanced multidetector spiral CT images 
demonstrate emboli (PE) in bilateral lower lobe 
pulmonary arteries. 
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and nuclear physicians 
at Mallinckrodt Institute 
of Radiology are working 
toward the common 
goal of reducing lung 
cancer mortality rates. 
by Candace O'Connor 
ung cancer is a formi- lung cancer than of breast, colon, 
dable disease. Every and prostate cancers combined, 
year, it kills nearly Lung cancer is difficult to 
160,000 men and women—most detect in time for a cure. Although 
of them smokers—and accounts for tiny breast cancers turn up on mam- 
some 28 percent of all cancer deaths mograms, colon cancers are found 
in the United States. It is, in fact, the during colonoscopy, and prostate 
leading cause of cancer death world- cancers are detected through PSA 
wide. More people die as a result of screening, there is no reliable 
screening test to detect lung cancer 
at an early, resectable stage. By the 
time patients develop symptoms, 
the cancer has usually invaded 
their mediastinal lymph nodes— 
and, despite the best chemotherapy 
and radiation therapy available, 
the five-year survival rate is only 
10 to 15 percent. 
r\ un cer 
nil III III 
to.  I! 
Richard Stone, MD 
"However, lung cancer is so 
common that even a small impact 
made on this disease can have a 
huge effect in the number of 
patients saved," says Jeffrey 
Bradley, MD, a radiation oncologist 
and chief of thoracic service at 
Mallinckrodt Institute of Radiol- 
ogy's (MIR) Radiation Oncology 
Center. "For example, if we can 
bump that survival rate up to 
twenty percent, we can save about 
eight thousand more lives in one 
year. So, new diagnostic tools and 
techniques can make a great differ- 
ence to patients." 
From the latest screening 
methods to newer, more aggressive 
therapies, MIR's radiologists and 
radiation oncologists are aggres- 
sively fighting nonsmall cell lung 
cancer while working to boost 
patient survival. 
Lung Cancer Screening 
In August 2000, Richard Slone, 
MD, associate professor of radi- 
ology, received a grant of nearly 
$400,000 from the National Cancer 
Institute (NCI) to participate in a 
pilot project called the Lung 
Screening Study. The study would 
assess the effectiveness of spiral 
computed tomography (CT), as 
compared to conventional chest 
X rays, in detecting asymptomatic 
lung cancer. The study, involving 
some 3,000 patients at six centers 
nationwide, would recruit people 
from 55 to 74 years of age who 
were current heavy smokers or 
were past smokers who had quit 
within the previous 10 years. 
The NCI sponsored this pilot 
project to test the feasibility of 
conducting a much larger, more 
definitive study that would again 
examine the efficacy of spiral CT 
for lung cancer screening and 
would also follow the patients long- 
term. There were some stumbling 
blocks for the project: Could Wash- 
ington University and the other 
centers recruit sufficient numbers 
of patients in a short time? Could 
they perform the exams, interpret 
the studies, and handle the logistics 
of sending reports to patients and 
physicians? 
Slone and his group answered 
these questions with a resounding 
"yes." In only 10 weeks, they man- 
aged to recruit, randomize, and 
image 500 patients—half of the 
patients received a single-view 
chest X ray; half received a low- 
dose spiral chest computed tomog- 
raphy examination. Altogether, a 
seven-member team worked full- 
time to complete the study on this 
fast-track schedule. Some of the 
team came from Volunteer for 
Health, an organization that 
matches appropriate patients with 
research studies, and helped in this 
study by handling telephone calls, 
patient eligibility checks, and 
scheduling. 
Lung Screening Study 
Research Assistants 
Roberta Yoffie, BS, RT, CCRC 
Sheila Agan, RT, (R)(CT) 
Danielle Gherardini, RN, BSN 
Robin Haverman, RT (R) 
Lora Crouch, BS, RT 
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The NCI was so pleased with 
the Washington University team's 
achievement that they awarded an 
additional grant of nearly $40,000 
to enroll an additional 100 patients 
beyond the original contract of 500. 
"We are considered one of the key 
contributing centers to this study, 
since we have been more success- 
ful than others at recruiting and 
managing the caseload," says 
Slone. "From the beginning, our 
goal was to play a key role in the 
next phase of this study." 
Slone's research focused on 
spiral CT, a technology that 
requires the patient to lie on a mov- 
able table within the CT scanner 
and hold one deep breath for 20 
seconds while the CT detectors 
rotate continually around the table. 
The resulting scan offers a detailed 
view of the chest, including the 
lungs, and may reveal tiny abnor- 
malities of just a few millimeters in 
size. The researchers compared 
these results to those of a chest 
X ray, which was first tested as a 
lung cancer screening tool during 
the late 1970s and early 1980s. 
Results showed that routine chest 
X rays do not have a significant 
impact on the ability to detect lung 
cancer early. 
Spiral CT is clearly a more sen- 
sitive, effective screening tool, and 
Slone's team has proven that use 
of spiral CT can be streamlined 
enough to be implemented as 
public health policy. However, 
the economic feasibility of this 
approach still needs to be resolved. 
And another issue remains: Does 
spiral CT detect cancers early 
enough to significantly impact the 
outcome of treatment? 
Over the coming year, Slone's 
study group will follow patients 
who have positive scans to see how 
many of these abnormalities prove 
to be cancerous. The researchers 
also will track the number of 
benign abnormalities that lead to 
additional testing and even surgery, 
with all the associated costs and 
risks. The next, much larger phase 
of testing, with its years of patient 
follow-up, will provide still more 
answers. 
"We hope spiral CT will prove 
to be a useful method for screening 
asymptomatic lung cancers. If it 
is useful, then what age groups of 
patients should be targeted? How 
much of a history of smoking 
should patients have? How often 
should patients be screened? We 
want to shed light on some of these 
questions," says Slone. 
Lung Cancer Treatment 
M! "allinckrodt Institute radiation oncologists are -involved in cutting-edge 
intramural and cooperative group 
protocols aimed at testing the lat- 
est lung cancer therapies and 
improving patient care. In one pilot 
intramural study, funded by a grant 
from the Siteman Cancer Center at 
Washington University Medical 
Center, radiation therapists are 
studying the use of CT combined 
with positron emission tomography 
(PET) to detect mediastinal lymph 
node involvement. 
Figure 1B 
Figure 1A and B: SYNCHRONOUS PRIMARY LUNG CANCERS 
Screening chest CT of asymptomatic 59 year-old man 
who had smoked 2 to 3 packs of cigarettes per day 
for over 30 years. Figure A shows lung destruction 
from pulmonary emphysema as well as a 1.5-cm spic- 
ulated pulmonary nodule in right upper lobe (arrow), 
highly suspicious for bronchogenic carcinoma. Figure 
B shows a 2-cm tabulated nodule in left lower lobe 
(arrow), also suspicious for bronchogenic carcinoma. 
Figure 2: NONBRONCHOGENIC MALIGNANCY Screening chest 
CT of asymptomatic 61 year-old man who had 
smoked 1 to 2 packs of cigarettes per day for over 
30 years. CT revealed a 3-cm tabulated mass in right 
lower lobe (arrow), suspicious for lung cancer. 




Above: Jeffrey Bradley, MD 
Below: These images represent an image-fused 
volumetric CT scan and PET scan for the purposes of 
radiation therapy planning. The gross tumor volume 
is contoured in red on the CT images on the left. 
The PET images show corresponding areas of FDG 
accumulation on the right. 
Developed at Mallinckrodt 
Institute in the early 1970s, PET is 
a noninvasive technique that uses 
radio-pharmaceuticals to provide 
vivid functional images of various 
organ systems. 
"CT scans alone have fifty to 
sixty percent sensitivity and speci- 
ficity in detecting this involvement, 
but the addition of PET scanning 
increases that number to eighty- 
five or ninety percent," says 
Bradley. "So by fusing these two 
types of imaging, the radiation ther- 
apist can target therapy more pre- 
cisely to the primary tumor and 
lymph nodes." 
Washington University is one 
of the leading patient recruiters 
for lung cancer protocols spon- 
sored by two large cooperative 
groups: the Radiation Therapy 
Oncology Group (RTOG) and the 
Cancer and Leukemia Group B 
(CALGB). One trial nearing com- 
pletion is RTOG 9311, developed by 
MIR's Radiation Oncology Center 
physicians and physicists. The 150 
patients in this trial have been 
treated with doses 
of 90-gray radiation or greater, an 
increase over the usual dose of 
60- or 70-gray, with no apparent 
toxicity. These patients will be 
followed until June 2001 to estab- 
lish their long-term reactions. 
Already, Bradley—in conjunc- 
tion with medical oncologist 
Ramaswamy Govindan, MD, and 
former MIR staff member Mary 
Graham, MD—has written a new 
protocol, RTOG 1051, to follow the 
9311 trial. This time, 
the physicians will escalate the 
dose of radiation therapy while 
using concurrent chemotherapy 
and will carefully gauge how high 
the dose can safely be raised. The 
data from this trial will be archived 
in a queriable database headquar- 
tered at MIR and will contain a 
wealth of knowledge about normal 
tissue tolerance to radiation in the 
chest. 
Along with clinical trials, the 
Institute is advancing lung cancer 
therapy in other aspects of care. In 
1991, the MIR Radiation Oncology 
Center pioneered the clinical use of 
three-dimensional conformal radia- 
tion therapy for planning and treat- 
ment. With the help of 
sophisticated, imaged-based com- 
puters, researchers can create an 
exact model of a patient's anatomy 
that allows for more precise calcu- 
lation of radiation doses. With this 
technique, higher and more effec- 
tive doses can be safely targeted to 
the tumor, and potential toxicity 
can be estimated and minimized. 
Currently, MIR researchers 
are also investigating an "active 
breathing control device" that 
teaches breath-holding techniques 
to patients, thus stopping respira- 
tory motion and improving the 
delivery of radiotherapy. 
The Radiation Oncology Center 
will soon acquire a new, highly 
sophisticated addition to the treat- 
ment arsenal: a state-of-the-art, 
large-bore CT simulator used for 
radiation therapy planning. While 
standard simulators have a 70-cen- 
timeter bore, this scanner has an 
85-centimeter opening that will 
accommodate larger patients. 
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Nuclear Medicine and 
Lung Cancer 
PET is one of the most impor- 
tant advances in imaging non- 
small cell lung cancer. The 
technology is beneficial in both the 
initial diagnosis and staging of lung 
cancer, where it has proven to be 
more sensitive and more specific 
than other imaging modalities. 
When patients are first diag- 
nosed with a pulmonary nodule, CT 
is most frequently used to charac- 
terize the nodule, but sometimes 
follow-up CT scans or a biopsy is 
needed to confirm. "PET is useful 
for differentiating benign from 
malignant nodules when the nodule 
is indeterminate by CT," says Far- 
rokh Dehdashti, MD, a nuclear 
medicine physician and an associ- 
ate professor of radiology. 
Currently, PET is routinely 
used at Washington University Med- 
ical Center, as well as other medical 
facilities, to stage patients with non- 
small cell lung cancer. Mallinckrodt 
Institute is currently participating 
in a prospective multicenter trial, 
sponsored by the American College 
of Surgeons Oncology Group, to 
further define the role of PET in 
staging lung cancer. 
In addition to detection and 
staging lung cancer, PET has a 
potential usefulness in monitoring 
and assessing response to therapy 
in patients with nonsmall cell lung 
cancer. 
Currently, Dehdashti and sev- 
eral colleagues—Mark Mintun, MD; 
Jason Lewis, PhD; Michael Welch, 
PhD; and Bradley and Govindan— 
are involved in a promising 
research study, funded by a grant 
from the National Institutes of 
Health (NIH). This study will 
assess a new positron-emitting 
tracer [60Cu-labeled diacetyl-bis 
(4N-methythiosemicarbazone) 
(^Cu-ATSM)] that can measure 
tumor hypoxia (oxygen defi- 
ciency), a critically important fac- 
tor in tumor behavior. Tumors 
with a high degree of hypoxia have 
been shown to be more malignant, 
more resistant to treatment, and 
more likely to metastasize or recur. 
Thus, these tumors require more 
aggressive treatment. 
In this study Dehdashti and 
her colleagues studied nonsmall 
cell lung cancers, using 60Cu-ATSM 
to measure tumor hypoxia. Then 
they compared the degree of 
hypoxia measured by PET with 
the patients' responses to therapy. 
Although results were preliminary, 
the team discovered an inverse 
relationship between the degree of 
tumor hypoxia and its response to 
therapy: Patients with a low level 
of hypoxia responded better to 
treatment than did those with a 
high degree of hypoxia. As these 
results indicate, PET may have 
an important impact on manage- 
ment of patients with nonsmall 
cell lung cancer. 
"This tracer will allow us to 
study therapeutic approaches that 
can improve tumor oxygenation by 
directly assessing the effect of such 
therapies on tumor hypoxia. This 
new PET tracer will also help us 
determine the regions of the tumor 
that are more hypoxic and, there- 
fore, more aggressive and resistant 
to therapy," says Dehdashti. Dm 
l\ 
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The unique advantages of having 
well-trained, experienced personnel and 
state-of-the-art equipment at Mallinckrodt 
Institute of Radiology is providing new 
hope for patents with aortic dissection. 
by Thomas Peters 
Suresh Vedantham, MD 
ortic dissection is 
the most common 
catastrophe of 
the aorta. If left 
untreated, 33 per- 
cent of patients 
with aortic dissection die within 
24 hours; by two weeks, the mortal- 
ity rate approaches 75 percent. 
Two thirds of the patients diagnosed 
with aortic dissection are treated 
immediately by surgical aortic 
reconstruction, a procedure that is 
very complex, requires a long recov- 
ery time, and can be life threatening 
for these critically ill patients. Cur- 
rently, at Mallinckrodt Institute of 
Radiology (MIR) and at only a 
few other medical centers in the 
world, revolutionary nonsurgical 
treatments are being created by 
coupling cutting-edge radiological 
and endovascular (inside the blood 
vessel) techniques. Together these 
nonsurgical approaches are quickly 
becoming viable and durable alter- 
natives to extensive reconstructive 
surgical procedures for patients 
with thoracic aortic dissection. 
The aorta is a large, elastic, 
multilayered blood vessel that 
comes from the heart and supplies 
blood to peripheral tissues and 
organs. Aortic dissection refers to a 
tear or hole in the inner elastic walls 
of the aorta that results in pulsatile 
blood flow moving through nonelas- 
tic outer layers of the aorta. In other 
words, blood flow forges a new path 
through the tear and into a very 
weak outer wall of the aorta that 
cannot respond well to the extreme 
forces of blood pressure. Although 
the exact causes of aortic dissection 
are not clear, patients with hyper- 
tension (high blood pressure) or 
Marian's disease are the most 
common victims of this condition. 
Over time this leak of pulsatile 
blood flow into the weaker sur- 
rounding layers of the aorta can 
lead to complications, including 
ballooning of the vessel walls 
(aneurysms), interruption of 
blood flow, and consequently oxy- 
gen to peripheral organs resulting 
in organ damage and/or eventually 
aortic rupture. 
Suresh Vedantham, MD, a 
vascular and interventional radiolo- 
gist at Mallinckrodt Institute of 
Radiology (MIR), is part of a multi- 
departmental effort at Washington 
University Medical Center (WUMC) 
to provide unique nonsurgical 
options for patients with aortic dis- 
section. "At our medical center, we 
are fortunate to have a good team 
approach for solving these types of 
complex problems," says Vedan- 
tham. "The number of institutions 
that have these cutting-edge treat- 
ment options is relatively small." 
Radiological diagnosis 
Patients with aortic dissection 
are often diagnosed with severe 
chest pain, often with associated 
ischemia (low oxygen), in one or 
more organs.   Once a patient is sus- 
pected of aortic dissection, imaging 
procedures can be performed to fur- 
ther identify whether the patient 
actually has aortic dissection. 
Angiography, often considered 
the standard radiological imaging 
procedure for identifying aortic 
dissections, has been replaced by 
newer, less invasive methods. 
Indeed, the aorta can be imaged 
radiologically by transesophogeal 
echocardiography (TEE), magnetic 
resonance imaging (MRI), or helical 
computed tomography (HCT). 
According to Vedantham, Washing- 
ton University Medical Center has 
the most current TEE, MRI, and 
HCT devices available. 
Mi, 
Figures 1A, IB, 1C: 
BALLOON FENESTRATION 
PROCEDURE TO RELIEVE 
LEFT LEG ISCHEMIA IN A 
PATIENT WITH AORTIC 
Figure A: Digital 
substruction 
angiogram shows 
severe collapse of 
aortic channel, or 
"true lumen," 
(arrowheads) that 
brings blood to left 
iliac artery and left 
leg. 
Figure B: Through 3 
to 4 mm incisions in 
each groin, a guided 
needle (arrow) is 
passed from left 
iliac artery into 
"false lumen" of 
the aorta. A 
catheter-mounted 
balloon (arrow- 
heads) in the false 
lumen is used as a 
target for the 
needle pass. 
Figure C: After new 
re-entry tear has 




blood flowing from 




tion, and into left 
leg (arrowheads). 
Figure 1C IIP 
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Figures 2A, 2B, 2C: 
AORTIC STENT PLACE- 
MENT IN A PATIENT WITH 
AORTIC DISSECTION 




(2 aortic channels, 
labeled A and B) 
with severe 
collapse of true 
lumen (arrows) of 
aorta in chest and 
upper abdomen. 
Arteries supplying 
liver, bowel, and 
right kidney are not 
seen because of 
poor blood flow. 
Artery to left kid- 
ney (arrowheads) 




3 to 4 mm 
incision in the 
groin, a metallic 
stent is placed in 
the aorta to expand 
and support col- 
lapsed true lumen, 
permitting more 
blood flow. Balloon   | 
angioplasty will 







of true lumen of 
the aorta with   . 
excellent blood   ' 
flow.   I 
Figure 2B 
"HCT is a great method for 
scanning rapidly. We can scan the 
aorta in sub-seconds, and this helps 
to decide if the patient is a candi- 
date for our aortic procedures," he 
says. "HCT is quickly becoming the 
best way to evaluate acute aortic 
dissection and its complications." 
After reviewing the radiological 
images, determining if the tear 
is in the descending aorta, and 
consulting with the other team 
members, patients are classified 
into two groups. 
Patients diagnosed with Stan- 
ford Type A dissection (involving 
the ascending aorta) are immedi- 
ately sent for surgical intervention 
because of the high risk of aortic 
rupture. Patients diagnosed with 
Stanford Type B dissection (involv- 
ing the descending aorta) without 
complications are managed with 
medications to reduce blood pres- 
sure and might be considered for 
stent-grafts in the future. 
Type B dissection patients who 
do show complications of organ 
ischemia were previously treated 
with emergency aortic surgery, 
but at Mallinckrodt Institute these 
patients are now considered key 
candidates for innovative, mini- 
mally invasive approaches. Dissec- 
tion complications can now be 
treated without the risks of major 
aortic surgery at the Institute and at 
a few other institutions worldwide. 
However, Vedantham cautions 
that "we never do these procedures 
without input from vascular sur- 
geons, cardiologists, and cardiotho- 
racic surgeons. Everyone on our 
medical team must collaboratively 
decide what is best for the patient." 
First generation of 
nonsurgical treatments 
According to Vedantham, the 
nonsurgical treatment of aortic 
dissection currently involves a "first 
generation" of radiological interven- 
tion techniques, including balloon 
fenestration and stent placement— 
both effective methods for treating 
the complications of dissection 
but not the dissection itself. Each of 
these techniques requires threading 
the balloon or stent devices through 
a catheter placed into an artery of 
the leg, as well as close radiological 
monitoring to help guide the 
devices to the aorta. Vedantham 
indicates these techniques are 
preferred since "they are a small 
operation through the groin instead 
of a massive operation in the chest." 
In balloon fenestration, the 
interventional radiologist makes a 
second, small tear in the aorta and 
below the initial tear. The radiolo- 
gist then uses an inflatable balloon 
to prop this tear open, thereby 
creating a small re-entry tear. This 
re-entry tear brings the blood flow 
back into the elastic-containing 
inner walls of the aorta, restoring 
blood flow into its important 
branches. One disadvantage of the 
balloon fenestration technique is 
the risk of puncturing the aorta 
with the needle used to create the 
second tear—although this rarely 
occurs with experienced interven- 
tional radiologists. 
Stents are small, expandable, 
metal mesh inserts that are placed 
in collapsed blood vessels to allow 
blood to again flow through the 
blood vessel and to help prevent 
future collapse of the blood vessel. 
Although only a limited number 
of patients have received the 
stent placement procedure in the 
MALLINCKRODT INSTITUTE OF RADIOLOGY 
thoracic aorta, the procedure has 
been effective in restoring blood 
flow into the compromised aortic 
branches, relieving the ischemia. 
One disadvantage is that stent 
placement often requires large 
areas of blood vessels to be encom- 
passed by these devices. Further 
studies must be performed to 
validate whether this is a viable 
long-term solution for complicated 
dissection. 
Both of these techniques 
require guidance by radiological 
monitoring systems, including fluo- 
roscopy (the standard procedure 
for most hospitals) or the more 
modern intravascular ultrasound, 
which is available at MIR. "Having 
access to intravascular ultrasound 
is another way to minimize the 
risks of the procedure. We can 
give patients less contrast dyes and 
prevent patients from developing 
complications," he says. 
Overall, these first-generation 
techniques have been successful in 
restoring blood flow to over 90 per- 
cent of ischemic organs in patients 
with complicated dissection. How- 
ever, remember the tear that gave 
rise to the aortic dissection is often 
not closed and, in the long term, 
may become more pronounced or 
may lead to further tears. Further- 
more, each procedure is difficult to 
translate to the general medical 
community because these lengthy 
procedures are performed on criti- 
cally ill patients and require well- 
trained staff and state-of-the-art 
radiological equipment available at 
only a few centers in the country. 
Second generation of 
treatments 
A new "second generation" 
approach that will soon be tested 
at WUMC involves placing a stent- 
graft across the primary tear of the 
dissection. The stent-graft is an 
expandable tube with a wall, 
whereas the stent is just expand- 
able mesh used to prop open blood 
vessels. Therefore, the stent-graft 
can cover the region of the blood 
vessel that has a tear and hold open 
the blood vessel simultaneously. 
"The number of patients 
treated with stent-grafts is small, 
but the graft is a promising solu- 
tion. We are creating the repair 
much like the surgeons do surgi- 
cally, but we are not exposing the 
patient to the upfront risks of 
having major surgery on the 
aorta," says Vedantham. 
Current and future studies 
Vedantham estimates that 
minimally invasive alternatives to 
aortic dissection are promising 
because of these three factors: 
improved biomaterials technology; 
improvements in imaging, includ- 
ing HCT, intravascular ultrasound, 
and digital subtraction angiogra- 
phy; and the current interest 
of biotechnology companies in 
pursuing less invasive methods 
of treating vascular diseases. He 
further explained that any proce- 
dure giving less invasive options 
to critically ill patients with aortic 
dissection requires further investi- 
gation of the long-term effects and 
whether that procedure can be 
expanded. Vedantham views 
stent-grafts as a major advance 
in the evolution of aortic dissection 
treatments. 
The Washington University 
Medical Center team 
Alan Braverman, MD, Internal Medicine 
David Hovsepian, MD, Vascular and 
Interventional Radiology 
Daniel Picus, MD, Vascular and 
Interventional Radiology 
Luis Sanchez, MD, Vascular Surgery 
Gregorio Sicard, MD, Vascular Surgery 
Thoralf Sundt, MD, Cardiothoracic 
Surgery 
Suresh Vedantham, MD, Vascular and 
Interventional Radiology 
Local hospitals have referred 
patients with Stanford Type B aor- 
tic dissection to WUMC with good 
results, and Vedantham believes 
the number of patient referrals will 
probably increase. "We hope the 
aortic stent-graft will develop into 
a treatment that can be applied not 
just to the complicated Type B 
patients with ischemia but to all 
Type B patients," he says. 
Overall, Vedantham indicates 
that the success of providing mini- 
mally invasive options to patients 
with aortic dissection can only 
occur through collaborative efforts, 
involving interventional radiolo- 
gists, vascular surgeons, cardiotho- 
racic surgeons, cardiologists, and 
attending critical care staff. EH3 
Editor's note: Vedantham recently 
coauthored "Nonoperative man- 
agement of acute aortic dissec- 
tion, " with Michael Dake, MD, of 
Stanford University. The scien- 
tific material appears as a book 
chapter in Current Therapy in Vas- 
cular Surgery. 
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In this section, the names of employees who are full-time fac- 
ulty or staff or who have an appointment in the Department 
of Radiology are highlighted in boldface type. 
PROMOTIONS 
Richard LaForest, PhD, 
research associate, was 
promoted to instructor in 
radiology, Division of 
Radiological Sciences. 
Mai Xu, PhD, research 
associate, was promoted 
to instructor in radiology, 
Radiation Oncology Center. 
NEW FACULTY 
Deepa Chadha, MD, 
instructor in radiology, 
Division of Diagnostic 
Radiology, Barnes-Jewish 
St. Peters Hospital. 
Mary Dyszlewski, PhD, 
visiting instructor in radiol- 
ogy, Division of Radiological 
Sciences. 
Susan Langhorst, PhD, 
CHP, assistant professor 
of radiology, Division of 
Radiological Sciences, and 
radiation safety officer and 
assistant director of environ- 
mental health and safety 
for Washington University 
Medical Center. 
Jie Zheng, PhD, instructor 




Thomas Conturo, MD, PhD, 
associate professor of radiol- 
ogy and adjunct assistant 
professor of physics, was 
appointed adjunct associate 
professor of physics and 
adjunct associate professor 
in biomedical engineering. 
Victor Song, PhD, research 
associate, Department of 
Chemistry, was appointed 
instructor in radiology, 




Hiten Malde, MD, is a clini- 
cal fellow in neuroradiology. 
He received an undergradu- 
ate degree from Valhind 
College of Science, India, 
and a medical degree from 
Grant Medical College, India. 
Malde completed four years 
of training in diagnostic radi- 
ology at New York Medical 
College, Valhalla. 
Paul Wong, MD, is a clini- 
cal fellow in neuroradiology. 
He received an undergradu- 
ate degree from Santa Clara 
University, California, and 
a medical degree from 
St. Louis University, Mis- 
souri. Wong completed 
four years of training in 
diagnostic radiology at the 
Kaiser Foundation Hospital, 
Los Angeles. 
APPOINTMENTS/ELECTIONS 
Kyongtae Bae, MD, PhD, 
assistant professor of radiol- 
ogy, was elected to a three- 
year term on the American 
College of Radiology's 
Committee on Drug and 
Contrast. 
Colin Derdeyn, MD, assis- 
tant professor of radiology, 
was appointed to the Editor- 
ial Board of the American 
Journal of Neuroradiology. 
Eric Klein, MS, assistant 
professor of radiology, was 
appointed to two-year terms 
on the American Society for 
Therapeutic Radiology and 
Oncology's Physics Commit- 
tee and the Refresher 
Course Subcommittee. 
Robert McKinstry, MD, 
PhD, assistant professor of 
radiology, was appointed 
director of the neuroradiol- 
ogy fellowship training 
program at Mallinckrodt 
Institute. 
Tom Miller, MD, PhD, 
professor of radiology, was 
appointed as a member of 
the American Board of 
Nuclear Medicine. 
Scott Mirowitz, MD, pro- 
fessor of radiology, chief 
of radiology at Barnes- 
Jewish Hospital north, and 
codirector of body magnetic 
resonance imaging, was 
appointed by the Board of 
Directors of the Radiological 
Society of North America to 
serve as chair of its Health 
Policy and Practice Commit- 
tee. Mirowitz has served on 
the committee since 1998. 
Jason Sohn, PhD, assistant 
professor of radiology, was 
named president-elect of the 
American Association of 
Physicists in Medicine, Mis- 
souri River Valley Chapter. 
Sally Wagner-Schwarz, 
MS, RPh, research instruc- 
tor in radiology, was 
appointed to the U.S. 
Nuclear Regulatory Commis- 
sion's Advisory Committee 
on Medical Use of Isotopes. 
Jeffrey Williamson, PhD, 
professor of radiology, 
was appointed to the U.S. 
Nuclear Regulatory Commis- 
sion's Advisory Committee 
on Medical Use of Isotopes. 
Franz Wippold, MD, pro 
fessor of radiology and chief 
of neuroradiology, was 
appointed to a one-year term 
on the American College of 
Radiology's Committee on 
Education—Neuro, Commis- 
sion on Neuroradiology & 
Magnetic Resonance. He 
was appointed as adjunct 
professor of radiology/ 
nuclear medicine by the 
F. Edward Hebert School 
of Medicine, Uniformed 
Services University of the 
Health Sciences, Bethesda 
Maryland. 
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obert Myerson, PhD, 
ID, professor of radiology, 
s principal investigator, 
'ceived a National Insti- 
ites of Health grant for 
esearch on "Simultaneous 
iiermoradiotherapy for 
ireast carcinoma." Coinves- 
igators for the grant are 
Eduardo Moros, PhD, 
associate professor of radi- 
ology; William Straube, 
MS, instructor in radiology; 
Marie Taylor, MD, instruc- 
tor in radiology; and Carlos 
Perez, MD, professor of 
radiology and director of the 
Radiation Oncology Center. 
Nobuyuki Oyama, MD, 
PhD, visiting instructor in 
radiology, received a 2000 
CaP CURE Research Award 
from the Association for 
the Cure of Cancer of the 
Prostate (CaP CURE) to 
fund research for one year 
on "PET imaging of prostate 
cancer recurrence: earlier 
diagnosis and treatment 
leading to better quality of 
life and prognosis." Coin- 
vestigators for the $100,000 
award are MIR's Tom 
Miller, MD, PhD, professor 
of radiology; Barry Siegel, 
MD, professor of radiology 
and of medicine; Farrokh 
Dehdashti, MD, associate 
professor of radiology; Jeff 
Michalski, MD, assistant 
professor of radiology; and 
Michael Welch, PhD, pro- 
fessor of radiology and of 
chemistry; and Washington 
University's Adam Kibel, 
MD; Gerald Andriole, MD; 
and Joel Picus, MD. 
Joseph Roti Roti, PhD, 
professor of radiology, 
associate director of the 
Radiation Oncology Center, 
and chief of cancer biology, 
as principal investigator, 
received a five-year, 
$1.4 million grant from the 
National Cancer Institute to 
study the molecular mecha- 
nisms that allow hyperther- 
mia to kill cancer cells. 
Jeffrey Williamson, PhD, 
professor of radiology, as 
principal investigator, 
received a five-year grant 
from the National Institutes 
of Health for research on 
"Heterogeneity corrections 
in brachytherapy." Coinves- 
tigators are Joseph Deasy, 
PhD, assistant professor of 
radiology; Clifford Chao, 
MD, assistant professor of 
radiology; and David Rogers, 
PhD, National Research 
Council of Canada. Collabo- 
rators on the grant are 
Sicong Li, DSc, research 
associate; Milos Vicic, 
PhD, research associate; 
and Randal Baker, PhD, Los 
Alamos National Laboratory. 
HONORS/ 
AWARDS 
Kyongtae Bae, MD, PhD, 
assistant professor of radiol- 
ogy, received an Editor's 
Recognition Award of 
Distinction 2000 from the 
journal Radiology. 
Louis Gilula, MD, professor 
of radiology and of surgery, 
was named organizer of the 
International Wrist Investiga- 
tive Workshop held in Octo- 
ber in Seattle, Washington. 
Barry Siegel, MD, professor 
of radiology and of medicine 
and director of the Division 
of Nuclear Medicine, 
received the American Board 
of Radiology's Distinguished 
Service Award for his "time,  . 
expertise, and energy 
donated toward the Ameri- 
can Board of Radiology's 
certification process." 
Carolyn Anderson, PhD, 
associate professor of radi- 
ology, presented "Copper- 
64-labeled somatostatin 
analogs for cancer imaging 
and therapy" at the Ameri- 
can Chemistry Society 
Regional Meeting, St. Louis, 
Missouri, October 26. 
Jeffrey Brown, MD, asso- 
ciate professor of radiology, 
director of clinical research, 
and codirector of magnetic 
resonance imaging, pre- 
sented "Abdominal MRA" 
and "MRI of the kidneys and 
pancreas" to the Colorado 
Radiological Society, Den- 
ver, October 19. He spoke 
on "MRI of the female 
pelvis" at Grand Rounds at 
the University of Colorado 
Department of Radiology, 
Denver, October 20. 
Clifford Chao, MD, assistant 
professor of radiology, spoke 
on "Head and neck IMRT: 
Washington University 
experience" at the IMRT 
Symposium: From Physics to 
Clinical Medicine, Milan, Italy, 
September 27-October 4. 
MIR receives digital 
patient monitoring 
systems 
Under a purchase agreement between Invivo 
Research, Inc. of Orlando, Florida, and MIR investi- 
gators Thomas Conturo, MD, PhD, and Robert Gro- 
pler, MD, chief of the cardiovascular imaging 
laboratory, MIR received two of the nation's first 
Invivo MAGNITUDE® MRI-compatible digital moni- 
toring systems, which received U. S. Food and Drug 
Administration approval in September, 2000. This 
revolutionary technology will provide more reliable, 
noninvasive physiologic monitoring (heart rate, oxy- 
gen saturation, and blood pressure), invasive moni- 
toring (arterial blood pressure), anesthesia 
monitoring (nitrous oxide, oxygen, and 5 vaporized 
anesthetics), and cardiac and pulse gating of MR 
imaging acquisitions. The MAGNITUDE15 systems will 
be used for neurologic and cardiac imaging research 
in MIR's East Building. 
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Colin Derdeyn, MD, assis- 
tant professor of radiology, 
as invited lecturer, spoke on 
"Emerging therapies: intra- 
arterial thrombolysis and 
carotid angioplasty and 
stenting" at the Stroke 
Prevention and Treatment 
in the New Millennium 
Symposium, sponsored 
by The Stroke Center at 
Washington University, 
St. Louis, October 14. 
Louis Gilula, MD, profes- 
sor of radiology and of 
surgery, as visiting profes- 
sor, presented "Ligamentous 
instabilities of the wrist" at 
the University of California, 
San Diego, August 18. He 
spoke on "Technical prob- 
lems of vertebroplasty and 
how to handle them" at the 
International Skeletal Soci- 
ety, Barcelona, Spain, Sep- 
tember 15. Gilula presented 
"Imaging approach to wrist 
pain" to the American Soci- 
ety of Plastic Surgeons, 
Los Angeles, October 11. 
He presented "Vertebro- 
plasty in osteoporosis" to 
the National Rehabilitation 
Society, San Francisco, 
November 3. He spoke on 
"Kyphoplasty vs. vertebro- 
plasty" at the Update on 
Spine Treatment, St. Louis, 
Missouri, November 11. 
Perry Grigsby, MD, MBA, 
professor of radiology, 
presented "Post-operative 
management of endometrial 
carcinoma" to the Jack- 
sonville Area Gynecologists/ 
Oncologists Society, Jack- 
sonville, Florida, August 22. 
He spoke on "Cervical can- 
cer: combined modality ther- 
apy" at the 2nd Annual 
National Oncology Forum, 
Chicago, Illinois, October 14- 
15. Grigsby presented "FDG- 
PET imaging for carcinoma 
of the cervix" and "Carci- 
noma of the thyroid in 
women" at the 10lh European 
InterUniversity Symposium: 
Highlights in Female Can- 
cers, Thessaloniki, Greece, 
November 2-5. He spoke on 
"Carcinoma of the ovary: 
role of radiotherapy" at the 
First International Confer- 
ence of Rajiv Gandhi Cancer 
Institute and Research Cen- 
ter, Delhi, India, November 
30-December 1. 
Jay Heiken, MD, professor 
of radiology, chief of abdom- 
inal radiology, and codirec- 
tor of body computed 
tomography, spoke on "Con- 
trast media physiology for 
multidetector CT," "Imaging 
of the liver and pancreas 
with multidetector CT," and 
"CT colonography: state of 
the art" at CT in the Year 
2000: Multidetector and 
Trauma CT, Milan, Italy, 
October 6 and 7. He pre- 
sented "Radiology of small 
bowel obstruction: role of 
plain films, CT, and barium 
studies" and "Spiral CT for ' 
the evaluation of patients 
with renal colic: Do we still 
need IVP?" at the Eighth 
Annual Radiology Update for 
the Clinician, Carbondale, 
Illinois, November 4. 
Anil Khosla, MD, instruc- 
tor in radiology, spoke on 
"High resolution BOLD 
venography in tumors" at the 
All India Institute of Medical 
Sciences, New Delhi, India, 
August 5. He presented 
"Extramedullary cysts of 
spine" at the Delhi Radiology 
Association, New Delhi, 
India, August 8. 
Moros discusses radio- 
frequency exposure systems 
In response to public concern about the possible 
health hazards caused by radiofrequency exposure, 
the U.S. Food and Drug Administration has formed 
the Radiofrequency Micronucleus Working Group. 
Eduardo Moros, PhD, associate professor of radiol- 
ogy, was invited to join this national and international 
team of scientific/technical experts. At the group's ini- 
tial meeting in August in RockvUle, Maryland, Moros 
discussed the in vitro radiofrequency exposure sys- 
tems and dosimetry research and development per- 
formed at MIR's Radiation Oncology Center. This 
public meeting was the first step of the Cooperative 
Research and Development Agreement formed 
between the FDA's Center for Devices and Radiologi- 
cal Health and the Cellular Telecommunications 
Industry Association. 
Jason Lewis, PhD, research 
instructor in radiology, pre- 
sented "Positron emission 
tomography (PET) as a diag- 
nostic tool in oncology" at 
Pharmacia, St. Louis, Mis- 
souri, October 5. Lewis 
spoke on "Copper-64-labeled 
somatostatin analogs for 
cancer imaging and therapy" 
at the American Chemistry 
Society Regional Meeting, St. 
Louis, Missouri, October 26. 
Daniel Low, PhD, assistant 
professor of radiology, spoke 
on "Difference between 
IMRT and conformal ther- 
apy" at University of Wiscon- 
sin, Madison, October 13, 
and at the Marconi Users 
Group Meeting, Boston, 
Massachusetts, October 20. 
Robert McKinstry, MD, 
PhD, assistant professor of 
radiology, as invited speaker 
for the American Medical 
Association/Intel Health Inter- 
net Roadshow, presented 
"Novice Internet training," 
"Web resources for physi- 
cians," "Web resources for 
consumers," and "Solutions 
for enhancing your practice 
to the Michigan State Medic,;il 
Society, Beverly Hills, Mich 
gan, September 14, and "Wi 
resources for physicians" a   1 
"Solutions for enhancing yr ir 
practice" to the Kentucky 
State Medical Society, 
Louisville, September 21. 
He spoke on "Diffusion ten;  r 
imaging of human neural 
development" at the Mappii 
Function and Anatomy in th 
Brain Symposium, sponson 
by the Department of Radio 
ogy, Michigan State Universi 
East Lansing, November 3. 
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ff Michalski, MD, assis- 
1   it professor of radiology, 
j   -sented "Radiation therapy 
a T localized prostate cancer" 
;  i he University of Arkansas 
I   clical Center, Fort Smith, 
,
L
 ptember 7. He spoke on 
'   ew perspectives on 
j   (state cancer: redefining 
j ;iient care" at the Medical 
I .lucation Collaborative, New 
K ork City, New York, Septem- 
i or 23. Michalski presented 
' New perspectives on 
i .restate disease: redefining 
1 latient care" at the Medical 
Education Collaborative, St. 
Louis, Missouri, October 27. 
lie spoke on "3D CRT and 
IMRT in pediatric clinical 
trials" at the Children's 
Oncology Group Meeting, 
Phoenix, Arizona, November 
2. Michalski presented 
"Pediatric brain tumor trials 
in the Children's Oncology 
Group" to the Greater St. 
Louis Society of Radiolo- 
gists, St. Louis, Missouri, 
November 21. 
Scott Mirowitz, MD, pro- 
fessor of radiology, chief of 
radiology at Barnes-Jewish 
Hospital north, and codirec- 
tor of body magnetic reso- 
nance imaging, as visiting 
professor, presented "MRI 
artifacts: challenges and 
solutions" and "MRI of the 
rotator cuff: techniques and 
interpretation at Grand 
Rounds" to the Department 
of Radiology, University of 
Missouri Medical Center, 
Columbia, October 31. 
Robert Myerson, PhD, 
MD, professor of radiology, 
spoke on "A joint U.S.-Italian 
phase I/II trial of three 
dimensionally planned con- 
current boost radiotherapy 
and protracted venous infu- 
sion of 5FU chemotherapy 
for locally advanced rectal 
carcinoma: response to 
treatment," Rome, Italy, 
November 17. 
Vamsidhar Narra, MD, 
assistant professor of radiol- 
ogy, presented "3D contrast 
enhanced MRA" to the 
Illinois State Society of 
Radiologic Technologists, 
Collinsville, Illinois, Septem- 
ber 22. He presented "3D 
contrast enhanced MRA 
and the value of VIBE" at 
William Beaumont Hospital, 
Royal Oak, Michigan, Octo- 
ber 4. He spoke on "MRCP 
for clinicians" at Michigan 
State University, Flint, Octo- 
ber 5. Narra presented "3D 
CE MRA" at the University 
of Louisville, and "MRCP" to 
the Greater Louisville Radio- 
logical Society, Louisville, 
Kentucky, October 18. He 
spoke on "Dynamic MRI in 
the evaluation of pelvic floor 
abnormalities" at the 86"' 
Annual College of the Ameri- 
can College of Surgeons, 
Chicago, Illinois, October 25. 
He presented "MRCP clini- 
cal applications: Can MRCP 
replace ERCP?" to the 
Carbondale Radiological 
Society, Carbondale, Illinois, 
November 4. 
Nobuyuki Oyama, MD, 
PhD, visiting instructor in 
radiology, as invited lecturer, 
presented "Clinical use of 
PET imaging in prostate 
cancer" to the Division of 
Nuclear Medicine, University 
of Washington, Seattle, 
August 28. 
James Purdy, PhD, profes- 
sor of radiology, associate 
director of the Radiation 
Oncology Center, and chief 
of radiation oncology 
physics, as invited lecturer, 
presented "Dose-volume 
specification and reporting 
for radiation oncology," 
"Quality assurance of 3D 
treatment planning sys- 
tems," "Quality assurance 
of 3D CRT and IMRT 
multi-institutional trials," 
and "Intensity modulated 
radiation therapy" at the 
4'" Annual National Sympo- 
sium for Radiation Oncol- 
ogy, Johannesburg, South 
Africa, August 21 and 22. 
As invited speaker, he 
presented "Image-based 
treatment planning" at the 
University of Witwater- 
strand, Johannesburg, South 
Africa, August 23. Purdy 
spoke on "Review of ICRU 
Reports 50 & 62: prescribing, 
recording, and reporting pho- 
ton beam therapy" and "Radi- 
ation therapy in the new 
millennium: future directions" 
at Tygerberg Hospital, Cape 
Town, South Africa, August 29 
and 30. 
Marcus Raichle, MD, 
professor of radiology and 
of neurology and neurobiol- 
ogy and codirector of the 
Division of Radiological 
Sciences, as the invited 
Willis Lecturer, presented 
"A default mode of brain 
function" to the Montreal 
Neurological Institute, Mon- 
treal, Canada, September 21. 
Joseph Roti Roti, PhD, 
professor of radiology, 
associate director of the 
Radiation Oncology Center, 
and chief of cancer biology, 
as invited speaker, pre- 
sented "Using animals to 
assess health effects of 
radiofrequency radiation 
from cell phones" to the 
Metro St. Louis Branch 
Association of Laboratory 
Animal Science, St. Louis, 
Missouri, October 19. 
Stuart Sagel, MD, profes- 
sor of radiology, chief of 
chest radiology, and codirec- 
tor of body computed 
tomography, spoke on "CT 
of asbestos-related thoracic 
disease," "CT of the pleura," 
"CT of non-vascular medi- 
astinal masses," and "Prob- 
lematic case discussions" 
at the Summer Practicum of 
the Society of Computed 
Body Tomography and Mag- 
netic Resonance, Whistler, 
British Columbia, August 
13-17. He spoke on "CT 
angiography for pulmonary 
embolism" and "CT of the 
thorax: anatomic variants 
and pitfalls" at the South 
Florida and University of 
Miami Radiological Meeting, 
Miami, Florida, September 
20. As visiting professor, 
Sagel presented "CT of 
non-vascular mediastinal 
masses," "CT of the thorax: 
anatomic variants and pit- 
falls," and "CT angiography 
for pulmonary embolism" 
to the Department of Radiol- 
ogy, Brown University, 
Providence, Rhode Island, 
October 2. 
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Barry Siegel, MD, profes- 
sor of radiology and of 
medicine and director of 
the Division of Nuclear 
Medicine, spoke on "PET in 
nuclear oncology: clinical 
applications" at the 7th Asia 
and Oceania Congress of 
Nuclear Medicine and Biol- 
ogy/41* International Con- 
gress of Nuclear Oncology, 
Istanbul, Turkey, October 2. 
In celebration of the open- 
ing of the first PET center in 
Turkey, Siegel, as invited 
speaker, presented "Onco- 
logical applications of PET" 
at International Hospital, 
Istanbul, October 3. He 
presented "PET imaging in 
oncology: overview of tumor 
imaging" and "Choices in 
positron imaging: PET" at 
the 14th Annual Northeast 
Regional Scientific Meeting 
of the New England and 
Greater New York Chapters 
of the Society of Nuclear 
Medicine, Newport, Rhode 
Island, November 3 and 4. 
Marilyn Siegel, MD, pro- 
fessor of radiology and of 
pediatrics, spoke on "Medi- 
astinal CT: pitfalls in chil- 
dren and adolescents," 
"Pediatric abdominal 
masses: imaging strategies," 
"Adolescent gynecologic 
lesions: CT/MRI," and 
"Pediatric kidney" at the 
10th Summer Practicum of 
the Society of Computed 
Body Tomography and Mag- 
netic Resonance Imaging 
Meeting, Whistler, British 
Columbia, August 13-17. As 
an invited speaker, she pre- 
sented "CT of the pediatric 
mediastinum" and "Spiral 
CT of the liver in children" 
at the Spiral/Helical CT 
2000: National Symposium, 
Las Vegas, Nevada, Septem- 
ber 7 and 8. As an invited 
guest speaker, she presented 
"CT/MR of pediatric 
retroperitoneal tumors," 
"Hepatic CT in children," 
"Ultrasonography of acute 
abdominal pain in children," 
and "MR imaging of bone 
marrow" at the New Orleans 
Fall Radiology Conference, 
New Orleans, Louisiana,   . 
September 21 and 22. Siegel 
spoke on "CT/MR imaging of 
abdominal pediatric tumors" 
at the International Cancer 
Imaging Society, 1st Annual 
Teaching Course, London, 
England, October 9 and 10. 
She presented "Sonography 
of neonatal intracranial 
hemorrhage and ischemia," 
"Pediatric gynecologic ultra- 
sonography," "Ultrasonogra- 
phy of neonatal renal 
disease," "Ultrasonography 
of acute abdominal pain in 
children," "CT of the pedi- 
atric kidney," and "CT and 
MRI of pediatric pelvic 
masses" at the 29"' Brazilian 
Congress of Radiology, 
Salvador da Bahia, Brazil, 
November 12-15. 
Jason Sohn, PhD, assistant 
professor of radiology, as 
invited lecturer, presented 
"Intensity modulated radia- 
tion therapy" at the Korean 
Society of Medical Physicists 
Annual Meeting, September 
22 and 23; at Seoul National 
University Medical School, 
September 25; at Samsung 
Medical Center, September 
27; and at Hallym University 
Medical Center, Seoul, 
Korea, September 27. 
Marie Taylor, MD, instruc- 
tor in radiology and chief of 
breast service, presented 
"Neoadjuvant therapy- 
radiation management for 
operable breast cancer" 
and "Management of local- 
regional recurrence after 
definitive treatment of oper- 
able breast cancer" at the 
Breast Cancer Symposium 
2000, Bangkok, Thailand, 
November 9 and 10. 
Jerold Wallis, MD, associ- 
ate professor of radiology, 
spoke on "Web-based image 
interpretation" at the Mis- 
souri Valley Chapter of the 
Society of Nuclear Medicine 
Annual Chapter Meeting, 
Des Moines, Iowa, October 8. 
Todd Wasserman, MD, 
professor of radiology, pre- 
sented "Protectors" at the 
Institute of Oncology, Chaim 
Sheba Medical Center, Tel- 
Hashomer, Israel, August 17, 
and to the Cancer Education 
Program-Tumor Board, 
Elkhart General Healthcare 
System, Elkhart, Indiana, 
December 20. He presented 
"Radiation protectors in 
clinical radiotherapy" to the 
Oncology Department of 
Rambam Medical Center, 
Haifa, Israel, August 21. He 
spoke on "Adjunctive care 
of the cancer patient: opti- 
mizing nutritional status for 
improved outcomes" at the 
SynerMed Development 
Meeting, Philadelphia, 
Pennsylvania, September 9. 
Wasserman spoke on 
"Ethyol and its clinical bene 
fits" at the U.S. Oncology 
Fall Conference, Phoenix, 
Arizona, October 9. He 
spoke on "Overviews of 
head and neck cancer and 
new strategies in radiopro- 
tection" at Medicom of 
Princeton, Inc., Augusta, 
Maine, November 27. He 
spoke on "Ethyol as a radio- 
protectant in head and neck 
cancers" at Medicom of 
Princeton, Inc., Cape Eliza- 
beth, Maine, November 28 
Michael Welch, PhD, pro- 
fessor of radiology and of 
chemistry and codirector  f 
the Division of Radiologic 1 
Sciences, presented "Cu- 
64-pyruvaldehyde-Ms(N4- 
methylthiosemicarbazon( 
(Cu-64-PTSM) as a radio- 
therapy agent to prevent i e 
growth of tumors at woui 1 
sites following laparosco]  " 
at the EANM Congress, 
Paris, France, September 
24 




Professorship and Lecture 
On September 25, Barbara Hertzberg, MD, professor 
of radiology and associate professor of obstetrics and 
gynecology at Duke University, presented the Eighth 
Annual G. Leland Melson Visiting Professorship and 
Lecture, "Ultrasound evaluation for ectopic preg- 
nancy." Hertzberg received a commemorative plaque 
from (left to right) Drs. Jay Heiken, chief of abdomi- 
nal radiology; Sharlene Teefey, ultrasound; and 
William Middleton, head of ultrasound. 
Jeffrey Williamson, PhD, 
professor of radiology, as 
invited speaker, presented 
"Dosimetry & calibration of 
low energy brachytherapy 
sources" at the Council of 
Ionizing Radiation Measure- 
ments and Standards Work- 
shop on a Measurements 
and Standards Infrastructure 
for Brachytherapy, Washing- 
ton, DC, October 30 and 31. 
Franz Wippold, MD, associ- 
ate professor of radiology 
and chief of neuroradiology, 
spoke on "Laryngeal cancer 
imaging" and "Cervical lymph 
nodes-anatomy and pathol- 
ogy" at the University of 
Montreal and at McGill Uni- 
versity, Montreal, Canada, 
September 12. He presented 
"Imaging the post therapy 
oral cavity and oropharynx" 
and a film interpretation ses- 
sion at the XV International 
Congress of Head and Neck 
Radiology, Kumamoto, 
Japan, October 19. 
In this section ofFYI, only 
those faculty and staff who 
have MIR appointments are 
listed. 
AMERICAN SOCIETY FOR 
THERAPEUTIC RADIOL- 
OGY AND ONCOLOGY 
(ASTRO) 
42nd Annual Meeting 
Boston, Massachusetts 
October 22-26, 2000 
James Purdy, PhD, ASTRO 
Gold Medal Award recipient. 
Imran Zoberi, MD, ASTRO 
Research Fellow Award 
recipient. 
REFRESHER COURSE 
David Gius, MD, PhD, 
"Novel combinations of 
biologic and radiation ther- 




Ana Botero, MD; Clifford 
Chao, MD; Ineke Duijn- 
dam, MD; Joseph Simp- 
son, MD, PhD; Carlos 
Perez, MD, "High dose 
radiation therapy yields 
satisfactory tumor control 
and the quality of voice as 
compared with those of 
hemilaryngectomy in early 
stage glottic carcinoma." 
Jeffrey Bradley, MD; 
Joseph Deasy, PhD; 
James Purdy, PhD; Todd 
Wasserman, MD; Nan- 
takan Ieumwananon- 
thachai, MD; Mary Ann 
Lockett, MBA, "Gross 
tumor volume is an indepen- 
dent predictor of survival in 
non-small cell lung carci- 
noma patients treated with 
conformal radiotherapy." 
Mustafa Cengiz, MD; Clif- 
ford Chao, MD; Carlos 
Perez, MD, "Intensity-mod- 
ulated radiotherapy (IMRT) 
with concurrent cisplatin 
chemotherapy (CT) yields 
superior therapeutic out- 
come than conventional 
techniques with or without 
chemotherapy in locally 
advanced nasopharyngeal 
carcinoma." 
Clifford Chao, MD; 
Joseph Deasy, PhD; 
Joanne Markham, MS; 
Carlos Perez, MD; James 
Purdy, PhD; Daniel Low, 
PhD, "Functional outcome 
of parotid gland sparing in 
patients with head and neck 
(H&N) cancers receiving 
intensity-modulated (IMRT) 
or 3-D radiation therapy." 
Clifford Chao, MD; Perry 
Grigsby, MD; Kim 
Nguyen, dosimetry QA spe- 
cialist; James Dempsey, 
PhD; Fritz Lerma, PhD; 
Kyongtae Bae, MD, PhD; 
Jeffrey Williamson, PhD, 
"Prospects for image-based 
dose planning of intracavi- 
tary brachytherapy: registra- 
tion of serial-imaging studies 
using deformable anatomic 
templates." 
Perry Grigsby, MD, MBA, 
"Long-term follow-up of 
RTOG 92-10: cervical cancer 
with positive para-aortic 
lymph nodes." 
Chih-Jen Huang, MD; 
Clifford Chao, MD; Carlos 
Perez, MD; Daniel Low, 
PhD, "Tumor response and 
salivary function sparing in 
patients with oropharyngeal 
squamous cell carcinoma 
treated with intensity 
modulated radiation therapy 
(IMRT) with/without 
chemotherapy: The 
Mallinckrodt Institute of 
Radiology initial results." 
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Shervin Karimpour, MD; 
Christopher Bradbury, 
research technician; Imran 
Zoberi, MD; Ana Botero, 
MD; David Gius, MD, PhD, 
"The role of thioredoxin 
reductase in the regulation 
of AP-1 DNA-binding activity 
and in the cytotoxic 
response to ionizing 
radiation." 
Eric Klein, MS; Daniel 
Low, PhD, "Interleaf leak- 
age testing for 0.5 and 
1.0 CM DMLC systems incor- 
porating patient motion." 
Daniel Low, PhD; James 
Dempsey, PhD; Joanne 
Markham, MS; Sasa 
Mutic, MS; Jeffrey 
Williamson, PhD; James 
Purdy, PhD, "Applicator- 
guided intensity modulated 
radiation therapy." 
Jeff Michalski, MD; James 
Purdy, PhD; Carlos Perez, 
MD; William Harms, BS, 
"Update of toxicity following 
3D radiation therapy for 
prostate cancer on RTOG 
9406." 
Jeff Michalski, MD; Wal- 
ter Bosch, DSc, "Mean dose 
of radiation to the bulb of 
the penis correlates with risk 
of impotence at 24 months: 
preliminary analysis of Radi- 
ation Therapy Oncology 
Group (RTOG) phase WI 
dose escalation trial 9406." 
Marie Taylor, MD; Carlos 
Perez, MD; Mary Ann 
Lockett, MBA, "The effect 
of medical co-morbidities of 
diabetes, hypertension and 
obesity on the incidence 
of arm edema after breast 
conservation therapy for 
stage I and II breast cancer- 
patients." 
Jeffrey Williamson, PhD, 
"Prospects for image-based 
dose planning of intracavi- 
tary brachytherapy: registra- 
tion of serial imaging studies 
using deformable anatomic 
templates." 
Imran Zoberi, MD, "The 
role of thioredoxin in the 
regulation of AP-1 DNA- 
binding and cytotoxicity 
in response to ionizing 
radiation." 
POSTER PRESENTATIONS 
Joseph Deasy, PhD, 
"Acceleration of monte carlo 
dose calculations via denois- 
ing techniques." 
Robert Drzymala, PhD; 
Jason Sohn, PhD; Eric 
Klein, MS, "Preliminary   ' 
study for frameless spinal 
radiosurgery using a stereo- 
optic camera system." 
Todd Grigereit, PhD; 
Daniel Low, PhD; Jennifer 
Britt, dosimetry QA special- 
ist; Jeffrey Bradley, MD, 
"Helical arc radiation 
therapy." 
*m      * 
fTj 
Scott Lecture 
Ronald Evens, MD, president of Barnes-Jewish 
Hospital and former director of Mallinckrodt Institute, 
was the Eg* Annual Wendell G. Scott Memorial Lecturer. 
On October 16 in Scarpellino Auditorium, Evens spoke 
on "Radiology from a hospital president's point of view." 
William Harms, BS; Rus- 
sell Gerber, MS; James 
Purdy, PhD, "Three dimen- 
sional conformal radiation 
therapy treatment planning 
and delivery verification 
for multi-institutional dose 
escalation trials using an 
anthropomorphic phantom." 
Jacob Locke, MD; Imran 
Zoberi, MD; Douglas 
Spitz, PhD; David Gius, 
MD, PhD, "Indomethacin 
induced inhibition of AP-1 
DNA-binding activity inhibits 
resistance of H202-resistant 
tumor cells to the cytotoxic- 
ity of hyperthermia, H202, 
and CIS-platin." 
Robert Myerson, PhD, 
MD; Anurag Singh, MD; 
Mary Ann Lockett, MBA. 
"Pre-treatment clinical find- 
ings predict outcome follow- 
ing preoperative radiation 
for rectal cancer." 
Jason Sohn, PhD; Dank 
Low, PhD; Eric Klein, MS, 
"Dynamic multileaf collim 




MALLINCKRODT INSTITUTE OF RADIO, 
R   IOLOGICAL SOCIETY 
0    ORTH AMERICA |(F m 
Scientific Assembly 
■a?<   Annual Meeting 
\C1   ago, Illinois 
\N<   •mber26- 
ID<   •mber 1,2000 
Louis Gilula, MD, presiding 
■officer, Musculoskeletal 
■(elbow, hand, and wrist). 
J;   Heiken, MD, presiding 
■officer, Gastrointestinal 
((T colonography: technical 
advances); keynote speaker, 
I Gastrointestinal. 
Gilbert Jost, MD, session 
[chair, Integrating the 
fealthcare Enterprise (IHE): 
clinical goals and technical 
I challenges. 
William Middleton, MD, 
presiding officer, Muscu- 
loskeletal ultrasound. 
Barry Siegel, MD, speaker, 
Opening Session, Positron 
emission tomography in 
clinical practice. 
Pamela Woodard, MD, 




Steven Don, MD, "Potential 
for reduced exposure 
to neonates through the 
use of chest computed 
radiography." 
SCIENTIFIC EXHIBITS 
Anil Khosla, MD; Franz 
Wippold, MD; Fred 
Hodges, MD, "Extra- 
medullary cysts of spinal 
canal." 
JeffMichalski, MD; Sasa 
Mutic, MS; John Eichling, 
PhD; Nisar Ahmed, MD, 
"Measured patient and 
family radiation exposure 
from permanent prostate 
brachytherapy." 
Mehdi Poustchi-Amin, 
MD; Pamela Woodard, 
MD; Fernando Gutierrez, 
MD; Jeffrey Brown, MD; 
Scott Mirowitz, MD; Vam- 
sidhar Narra, MD, "Practi- 
cal cardiac MRI: principles 
and applications, a review 
for the general radiologist." 
REFRESHER COURSES 
Dennis Balfe, MD, "Imaging 
the invisible: mesenteries and 
peritoneum of the upper 
abdomen." 
Jeffrey Brown, MD, "MR 
of the genitourinary tract." 
Joseph Deasy, PhD, 
"Update course in diagnostic 
radiology physics: radiation 
therapy optimization and 
intensity-modulated radia- 
tion therapy—radiobiologi- 
cal issues of optimization 
and intensity-modulated 
radiation therapy." 
Louis Gilula, MD, "Verte- 
broplasty: indications, 
technique, problems, and 
complications;" "Imaging 
upper-extremity trauma with 
plain films, CT, and MR;" 
"Wrist and hand injuries." 
Fernando Gutierrez, MD, 
"Update course in pediatric 
radiology: imaging advances 
in 2000—cardiovascular 
disease. Vascular anomalies: 
mediastinum and lung." 
Jay Heiken, MD, "Acute 
abdomen: CT evaluation." 




Elizabeth McFarland, MD, 
"CT of the small bowel and 




The Norman K. Probstein Oncology Lecture, in recog- 
nition of meritorious contributions to oncology, was 
presented on November 3 by Jonathan Epstein, MD, 
professor of pathology at Johns Hopkins University 
School of Medicine. He spoke on "Prognostic factors 
in prostate cancer." 
JeffMichalski, MD, "Radi- 
ation therapy for prostate 
cancer: dose escalation 
with 3D conformal radiation 
therapy." 
William Middleton, MD, 
"Musculoskeletal US ('hands- 
on' workshop);" "Practical 
tips in ultrasound: hand and 
wrist." 
James Purdy, PhD, 
"Update course in diagnostic 
radiology physics: radiation 




David Rubin, MD, "Imaging 
upper-extremity trauma with 
plain films, CT, and MR: 
shoulder injuries." 
Stuart Sagel, MD, 
"Digital chest radiography: 
techniques and clinical 
applications." 
Barry Siegel, MD, "Opti- 
mizing PET interpretation." 
Marilyn Siegel, MD, 
"Update course in pediatric 
radiology: imaging advances 
in 2000—pelvis: US, CT, or 
MR imaging? Uterine anom- 
alies;" "Pediatric MR imag- 
ing: abdominal masses." 
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SCIENTIFIC SESSIONS 
Kyongtae Bae, MD, PhD; 
Alvaro Huete, MD; Far- 
rokh Dehdashti, MD; Jay 
Heiken, MD, "Characteriza- 
tion of adrenal adenoma 
with PET in oncology 
patients." 
Kyongtae Bae, MD, PhD; 
Jeong Lee, MD; Bruce 
Whiting, PhD; Jay Heiken, 
MD, "Evaluation of multi- 
slice CT scan parameters for 
renal artery stenosis depic- 
tion: in vitro analysis." 
Thomas Conturo, MD, 
PhD; Nicholas Lori; Erbil 
Akbudak, PhD; Abraham 
Snyder, MD, PhD; Robin 
Guillory; Joshua Shimony, 
MD, PhD, "MRI diffusion 
tensor tracking of neuronal 
pathways of the visual 
system in living humans." 
Juliet Fallah, MD; Marilyn 
Siegel, MD, "Post-trans- 
plant lymphoproliferative 
disorder and non-Hodgkins 
lymphoma: comparison of 
CT findings in abdominal 
disease." 
David Gierada, MD; 
Thomas Pilgram, PhD; 
Richard Slone, MD; Lora 
Crouch, BSRT, "Reliability 
of quantitative CT (QCT) in 
determining emphysema 
severity and distribution 
in lung volume reduction 
surgery candidates." 
Louis Gilula, MD; Dallas 
Peck, MD, "Percutaneous 
vertebroplasty for severe 
osteoporotic vertebral com- 
pression (vertebra plana)." 
Jay Heiken, MD; Cary 
Siegel, MD, "Attenuation 
of renal cysts with conven- 
tional and spiral CT: a phan- 
tom study." 
Ronan McDermott, MD; 
Sharlene Teefey, MD; 
William Middleton, MD; 
Charles Hildebolt, DDS, 
PhD, "The resistive index 
in renal parenchymal dis- 
ease: no correlation with 
histopathological findings." 
William Middleton, MD; 
Sharlene Teefey, MD, 
"Interobserver variability in 
sonographic detection of 
rotator cuff tears." 
William Middleton, MD; 
Sharlene Teefey, MD; 
Cynthia Santillan, MD; 
Elizabeth McFarland, MD; 
Shadan Sadeghi, "Prospec- 
tive evaluation of the inci- 
dence of testicular of 
microlithiasis and its associ- 
ation with testicular tumors." 
Scott Mirowitz, MD, 
"Health services, policy, and 
research;" "Radiology utiliza- 
tion patterns in an academic 




MD, chief of radia- 
tion oncology at the 
National Cancer 
Institute/National 
Institutes of Health 
in Bcthcsda, pre- 
sented the Ninth Annual Leonard J. Tolmach 
Memorial Lecture on November 3. The lecture topic 
was "Radiation oncology: linking technology and 
biology in the treatment of cancer." 
Pratik Mukherjee, MD, 
PhD; Robert McKinstry, 
MD, PhD, "Diffusion tensor 
MR imaging of the reversible 
posterior leukoencephalopa- 
thy syndrome." 
Dallas Peck, MD; Louis 
Gilula, MD, "Technical 
problems and potential solu- 
tions in vertebroplasty." 
Sharlene Teefey, MD; 
William Middleton, MD, 
"Detection of partial and full 
thickness rotator cuff tears 
in patients with a painful 
shoulder: a comparison of 
ultrasound, MRI, and arthro- 
scopic surgery." 
Bruce Whiting, PhD; 
Kyongtae Bae, MD, PhD, 
"Novel method of CT data 
reduction by compression of 
projection sinograms." 
Dmitriy Yablonskiy, PhD, 
"Gradient echo plural con- 
trast imaging (GEPCI)—new 
fast magnetic resonance 
imaging technique for simul- 
taneous acquisition of T2, Tl 
(or spin density) and T2*- 
weighted images." 
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